跳至主要内容
临床试验/JPRN-UMIN000013727
JPRN-UMIN000013727Enrolling By Invitation未知

Efficacy of Tolvaptan in acute heart failure patients with preserved left ventricular ejection fractio

Osaka General Medical Center0 个研究点目标入组 120 人开始时间: 2014年4月16日最近更新:
适应症

试验速览

阶段
未知
状态
Enrolling By Invitation
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 90years-old(—)
性别
All

入选标准

  • 1) Patients with left ventricular ejection fraction>=45%
  • 2) Patients with at least one sign of congestion (edema, pulmonary congestion, pleural effusion, jugular venous distention, orthopnea)
  • 3)Patients who received sufficient explanation, understood it and gave written consent based on their free will, before participating in this study

排除标准

  • 1) Patients with hypernatremia (Na>147mEq/L)
  • 2) Patients who do not need diuretic therapy because of dehydration
  • 3) Patients with cardiovascular shock
  • 4) Patients with anuria or patients under hemodialysis
  • 5) Patients with acute coronary syndrome
  • 6) Patients with insensitivity to thirst or difficulty in water intake
  • 7) Patients who need mechanical circulatory assist device (IABP?PCPS)
  • 8) Patients with malignant tumor
  • 9) Patients who need temporary pacing because of bradycardia
  • 10) Patients who were judged inappropriate by the principal investigator

研究者

相似试验